Tilray Brands, Inc. Business Combination, Acquisition Related Costs
Tilray Brands, Inc. (TLRY) reported Business Combination, Acquisition Related Costs of $0 for the 12-month period ending 2023-05-31, per its 10-K filed 2023-07-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2023-07-26
- Tilray Brands, Inc. business combination, acquisition related costs for the quarter ending 2023-05-31 was $3.88M.
- Tilray Brands, Inc. business combination, acquisition related costs for the quarter ending 2023-02-28 was $5.38M, a 7.15% increase year-over-year.
- Tilray Brands, Inc. business combination, acquisition related costs for the quarter ending 2022-11-30 was $5.06M, a 28.07% decline year-over-year.
- Tilray Brands, Inc. business combination, acquisition related costs for the quarter ending 2022-08-31 was -$12.82M, a 152.56% decline year-over-year.
- Tilray Brands, Inc. business combination, acquisition related costs for fiscal 2023 was $0.00.
- Tilray Brands, Inc. business combination, acquisition related costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Tilray Brands, Inc. business combination, acquisition related costs for fiscal 2021 was $59.92M.
- Tilray Brands, Inc. business combination, acquisition related costs for fiscal 2019 was $11.66M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2023-05-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $9.26M derived: sum of 2 quarters · filed 2023-07-26 | $14.33M derived: sum of 3 quarters · filed 2023-07-26 | $0.00 10-K · filed 2023-07-26 |
| 2023-02-28 | $5.38M 10-Q · filed 2023-04-10 | $10.45M derived: sum of 2 quarters · filed 2023-04-10 | -$3.88M 10-Q · filed 2023-04-10 | -$38.02M derived: sum of 4 quarters · filed 2023-07-26 |
| 2022-11-30 | $5.06M 10-Q · filed 2023-01-09 | -$7.75M 10-Q · filed 2023-01-09 | -$43.41M derived: sum of 3 quarters · filed 2023-07-26 | -$38.38M derived: sum of 4 quarters · filed 2023-07-26 |
| 2022-08-31 | -$12.82M 10-Q · filed 2022-10-07 | -$48.47M derived: sum of 2 quarters · filed 2023-07-26 | -$43.45M derived: sum of 3 quarters · filed 2023-07-26 | -$36.41M derived: sum of 4 quarters · filed 2023-07-26 |
| 2022-05-31 | -$35.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$30.63M derived: sum of 2 quarters · filed 2023-07-26 | -$23.59M derived: sum of 3 quarters · filed 2023-07-26 | $0.00 10-K · filed 2023-07-26 |
| 2022-02-28 | $5.02M 10-Q · filed 2023-04-10 | $12.06M derived: sum of 2 quarters · filed 2023-04-10 | $35.65M 10-Q · filed 2023-04-10 | $71.20M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | $7.04M 10-Q · filed 2023-01-09 | $31.43M 10-Q · filed 2023-01-09 | $66.18M derived: sum of 3 quarters · filed 2023-07-26 | $77.44M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $24.39M 10-Q · filed 2022-10-07 | $59.14M derived: sum of 2 quarters · filed 2023-07-26 | $70.41M derived: sum of 3 quarters · filed 2023-07-26 | |
| 2021-05-31 | $34.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $46.02M derived: sum of 2 quarters · filed 2023-07-26 | $59.92M 10-K · filed 2023-07-26 | |
| 2021-02-28 | $11.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $25.16M 10-Q · filed 2022-04-06 | ||
| 2020-11-30 | $13.90M 10-Q · filed 2022-01-10 | |||
| 2020-06-30 | $1.79M 10-Q · filed 2020-08-10 | $4.14M 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | $2.35M 10-Q · filed 2020-05-11 | |||
| 2019-06-30 | $2.46M 10-Q · filed 2020-08-10 | $6.89M 10-Q · filed 2020-08-10 | ||
| 2019-05-31 | $11.66M 10-K · filed 2021-07-28 | |||
| 2019-03-31 | $4.42M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |